The FDA has sent out an alert regarding Meridian Medical Technologies’ Mylan EpiPen and EpiPen Jr. (epinephrine injection) that are used to treat severe allergic reactions. The company has voluntarily recalled 13 EpiPen lots, distributed between Dec. 17, 2015 and July 1, 2016.
Device failure reports have been few, but the risk of potential life-threatening allergic reactions brought about the company’s voluntary recall. The impacted lots may contain defective components that would cause the EpiPen to not activate.
Consumers are urged to keep and use their EpiPens until they are provided with a replacement and per the product label, seek emergency medical attention immediately after using their EpiPens, especially if the device did not activate.
Please see the FDA’s official communication for more information.
LEAVE A REPLY